Oramed Pharmaceuticals Inc (ORMP NASDAQ) stock market data APIs
$3.2492
0.12(3.7%)
as of February 11, 2026
Try our APIs with
free plan!
Oramed Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Prev. Close
3.2492
Open
3.3726
High
3.43
Low
3.2159
52 wk Range
1.6967-3.71
Market Cap
130 M
P/E Ratio
3.3854
Shares Outstanding
39 802 K
Revenue
2 000 K
EPS
0.15
Dividends (Yield)
0
Beta
1.308
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Oramed Pharmaceuticals Inc data using free add-ons & libraries
Get Oramed Pharmaceuticals Inc Fundamental Data
Oramed Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 2 000 K
- EBITDA: -12 889 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-17
- EPS/Forecast: -0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Oramed Pharmaceuticals Inc News
New
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
On February 2, BML Capital Management, LLC disclosed a new position in CarMax(NYSE:KMX), acquiring 155,000 shares in an estimated $5.99 million trade based on quarterly average pricing. What happened...
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
On February 2, BML Capital Management disclosed in a Securities and Exchange Commission filing that it sold out of Alumis(NASDAQ:ALMS), liquidating 1,210,415 shares in an estimated $4.83 million trade...
3 Promising Penny Stocks With Market Caps Under $200M
As the S&P 500 and Dow Jones Industrial Average reach new highs, investors continue to navigate a landscape marked by both opportunities and challenges. For those looking to invest in smaller or newer...
Oramed To Transfer POD Technology To Lifeward; To Receive 49.9% Beneficial Ownership Interest
(RTTNews) - Oramed Pharmaceuticals Inc. (ORMP) and Lifeward Ltd. (LFWD) announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited invest...
Get Oramed Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
